Literature DB >> 15238779

Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopes.

Tara Beattie1, Rupert Kaul, Tim Rostron, Tao Dong, Philippa Easterbrook, Walter Jaoko, Joshua Kimani, Francis Plummer, Andrew McMichael, Sarah Rowland-Jones.   

Abstract

The IFN-y enzyme-linked immunospot (ELI-Spot) assay is often used to map HIV-specific CD8 T-cell responses. We compared overlapping 15-mer pools with optimized CD8 epitopes to screen ELISpot responses in HIV-infected individuals. The 15-mer pools detected responses to previously undefined epitopes, but often missed low-level responses to predefined epitopes, particularly when the epitope was central in the 15-mer, rather than at the N-terminus or C-terminus. These factors should be considered in the monitoring of HIV vaccine trials.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15238779     DOI: 10.1097/01.aids.0000131362.82951.b2

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  22 in total

1.  Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques.

Authors:  Adrian B McDermott; David H O'Connor; Sarah Fuenger; Shari Piaskowski; Sarah Martin; John Loffredo; Matthew Reynolds; Jason Reed; Jessica Furlott; Timothy Jacoby; Cara Riek; Elizabeth Dodds; Kendall Krebs; Mary-Ellen Davies; William A Schleif; Danilo R Casimiro; John W Shiver; D I Watkins
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  Breast milk HIV-1 RNA levels and female sex are associated with HIV-1-specific CD8+ T-cell responses in HIV-1-exposed, uninfected infants in Kenya.

Authors:  Carey Farquhar; Barbara Lohman-Payne; Julie Overbaugh; Barbra A Richardson; Jennifer Mabuka; Rose Bosire; Dorothy Mbori-Ngacha; Grace John-Stewart
Journal:  J Infect Dis       Date:  2011-10-07       Impact factor: 5.226

3.  Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution.

Authors:  Bin Li; Adrianne D Gladden; Marcus Altfeld; John M Kaldor; David A Cooper; Anthony D Kelleher; Todd M Allen
Journal:  J Virol       Date:  2006-10-25       Impact factor: 5.103

4.  Nondominant CD8 T cells are active players in the vaccine-induced antitumor immune response.

Authors:  Jennifer N Uram; Chelsea M Black; Emilee Flynn; Lanqing Huang; Todd D Armstrong; Elizabeth M Jaffee
Journal:  J Immunol       Date:  2011-02-23       Impact factor: 5.422

5.  Human endogenous retrovirus K(HML-2) Gag- and Env-specific T-cell responses are infrequently detected in HIV-1-infected subjects using standard peptide matrix-based screening.

Authors:  R Brad Jones; Vivek M John; Diana V Hunter; Eric Martin; Shariq Mujib; Vesna Mihajlovic; Peter C Burgers; Theo M Luider; Gabor Gyenes; Neil C Sheppard; Devi Sengupta; Ravi Tandon; Feng-Yun Yue; Erika Benko; Colin Kovacs; Douglas F Nixon; Mario A Ostrowski
Journal:  Clin Vaccine Immunol       Date:  2011-12-28

6.  Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants.

Authors:  Barbara L Lohman; Jennifer A Slyker; Barbra A Richardson; Carey Farquhar; Jenniffer M Mabuka; Christopher Crudder; Tao Dong; Elizabeth Obimbo; Dorothy Mbori-Ngacha; Julie Overbaugh; Sarah Rowland-Jones; Grace John-Stewart
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  Broad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservation.

Authors:  Mark J Geels; Sheri A Dubey; Kiersten Anderson; Elly Baan; Margreet Bakker; Georgios Pollakis; William A Paxton; John W Shiver; Jaap Goudsmit
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 8.  The potential role of biomarkers in HIV preventive vaccine trials.

Authors:  Ellen Maclachlan; Kenneth H Mayer; Ruanne Barnabas; Jorge Sanchez; Beryl Koblin; Ann Duerr
Journal:  J Acquir Immune Defic Syndr       Date:  2009-08-15       Impact factor: 3.731

9.  Multiple T-cell responses to human immunodeficiency virus type 1 are enhanced by dendritic cells.

Authors:  Xiao-Li Huang; Zheng Fan; Luann Borowski; Charles R Rinaldo
Journal:  Clin Vaccine Immunol       Date:  2009-08-19

10.  Peptide impurities in commercial synthetic peptides and their implications for vaccine trial assessment.

Authors:  Jeffrey R Currier; Lynee M Galley; Holger Wenschuh; Vivian Morafo; Silvia Ratto-Kim; Clive M Gray; Leonard Maboko; Michael Hoelscher; Mary A Marovich; Josephine H Cox
Journal:  Clin Vaccine Immunol       Date:  2007-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.